MUFG Securities Americas’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.4M Buy
53,213
+4,319
+9% +$929K 0.69% 24
2026
Q1
$10.6M Buy
48,894
+1,280
+3% +$284K 0.69% 21
2025
Q4
$10.9M Sell
47,614
-24
-0.1% -$5.47K 0.68% 20
2025
Q3
$11M Buy
47,638
+8,490
+22% +$1.73M 0.71% 22
2025
Q2
$7.27M Buy
39,148
+7,899
+25% +$1.47M 0.62% 24
2025
Q1
$6.55M Buy
31,249
+5,163
+20% +$1M 0.76% 24
2024
Q4
$4.64M Buy
+26,086
New +$4.8M 0.59% 30

Other funds holding ABBV

MUFG Securities Americas's ABBV Position: Q2 2026 in Review

MUFG Securities Americas increased its AbbVie (ABBV) stake by 8.8% in Q2 2026, buying an estimated $929K and bringing the position to 53,213 shares worth $13.4M. The position accounts for 0.69% of the portfolio, ranked #24.

MUFG Securities Americas first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • MUFG Securities Americas held 53,213 shares of AbbVie worth $13.4M as of Q2 2026.
  • MUFG Securities Americas bought 4,319 AbbVie shares in Q2 2026, an estimated $929K.
  • AbbVie made up 0.69% of MUFG Securities Americas's portfolio in Q2 2026, its #24 holding.
  • MUFG Securities Americas first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MUFG Securities Americas's 13F filing for Q2 2026, filed 14 Aug 2026.